[ad_1]
WHO Director-General Dr. Tedros Adhanom Ghebreyesus held a videoconference meeting with WHO epidemic experts at WHO headquarters in Geneva, Switzerland.
Correspondent for AA, Turkey, USA, Russia, China and questions about the recent situation in England on vaccine studies, scientific delegation of WHO Chief Specialist Dr Soumya Swaminathan and WHO Deputy Director-General , Dr. Mariangela Simao answered.
Swaminathan said they closely follow vaccine studies around the world: “It is really encouraging to see the progress in clinical trials around the world. As you know, we currently have around 40 candidate vaccines in some stages of clinical trials, and 10 of them are in the final phase of the PHASE-3 trials. last stage vaccines) will give us information both in terms of efficacy and safety of the vaccines, “he said.
READY ON EARTH 2021
Dr. Swaminathan reported that the Covid-19 vaccine will be available in December or early 2021 for regulatory approval.
Scientist Swaminathan noted that having many candidates for Covid-19 increases the chances of finding an effective and safe Covid-19 vaccine.
YOU NEED TO BE LICENSED
WHO Deputy Director General and Medicines and Health Products Officer Dr. Simao said: “This vaccine must be licensed in the country where the trial was conducted, in the country where it was tested.”
Stating that the WHO is working very closely with national regulatory authorities for the Covid-19 vaccine, Simao noted that many steps must be taken for widespread vaccination after the FAZ-3 trials actually end.
